Stock Market Research

Article

What’s NVIDIA’s Stock Really Worth? Now’s the Right Time to…

Jul 22, 2024

It's a race to develop the world's highest-performance AI accelerators. Will the Computing King continue to wear the AI crown?

Article

Domino’s Pizza: On Sale, But Still Not a Bargain

Jul 18, 2024

The pizza chain's stock went on sale today, though it still doesn't look particularly appetizing.

Article

NIKE: Short-Term Pain, Long-Term Gain?

Jul 16, 2024

Is the global athletic wear king current an excellent investment opportunity?

Article

Cassava Sciences: Is The Fraud Investigation Just Smoke…or an Actual…

Jul 1, 2024

This micro-cap biotech company is working on an innovative cure to Alzheimer's Disease but is surrounded by controversy. Is it worth the risk for investors?

Article

A Tale of Two Cybersecurity Leaders

Jun 10, 2024

Article

Illumina Officially Ends Its Quest for the Holy GRAIL

Jun 7, 2024

After feeling the heat from investors, customers, and regulators, Illumina has finally agreed to divest GRAIL.

Article

50 Quotes from Legendary Value Investor Joel Tillinghast

May 24, 2024

Guest writer John Rotonti shares several of the best quotes from legendary value investor Joel Tillinghast.

Article

dLocal’s Margins Compress; Announces Stock Buyback

May 23, 2024

The international payment processor had a mixed quarter. See our key takeaways for investors.

Article

Introducing 7investing’s Stockpicking Competition!

Mar 4, 2024

Enter to win a $1,000 Amazon gift card and a free year of 7investing.

Article

Is Tech Hiring Picking Back Up?

Feb 15, 2024

Encouraging data shows that (some) tech companies are looking for new engineering talent.

Article

AI is Bringing Synthetic Biology Back to Life

Feb 6, 2024

New AI tools could supercharge the emerging field of generative biology. The therapeutics segment might be a natural fit.

Article

Investing in the Cloud: Mission-Critical, Land-and-Expand, and Sustainable Growth

Jan 22, 2024

Guest contributor Anand Khatri from StocksCurrent describes how investors should approach the cloud computing industry.

Article

2024 NFL Mock Draft 1.0

Jan 21, 2024

7investing CEO Simon Erickson shares his mock draft outlook of what NFL fans should expect this April.

Article

Why Seres Therapeutics is My Best Buy in January

Jan 17, 2024

The market's first microbiome company is getting a good reception to its first commercially-approved drug.

Article

ZoomInfo: Time for a Turnaround?

Jan 11, 2024

The sales platform looks primed for a turnaround.